291 related articles for article (PubMed ID: 6330154)
1. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
Snowden EU; Khan-Dawood FS; Dawood MY
J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
[TBL] [Abstract][Full Text] [Related]
2. Effects of naloxone and an enkephalin analog on serum prolactin, cortisol, and gonadotropins in the chimpanzee.
Gosselin RE; Blankstein J; Dent DW; Hobson WC; Fuller GB; Reyes FI; Winter JS; Faiman C
Endocrinology; 1983 Jun; 112(6):2168-73. PubMed ID: 6406210
[TBL] [Abstract][Full Text] [Related]
3. On the correlation of luteinizing hormone-releasing hormone, luteinizing hormone, follicle-stimulating hormone, and prolactin levels in plasma of women with normal menstrual cycles.
Aksel S
Am J Obstet Gynecol; 1981 Oct; 141(4):362-7. PubMed ID: 6792924
[TBL] [Abstract][Full Text] [Related]
4. Synchronous secretion of luteinizing hormone and prolactin in the human luteal phase: neuroendocrine mechanisms.
Braund W; Roeger DC; Judd SJ
J Clin Endocrinol Metab; 1984 Feb; 58(2):293-7. PubMed ID: 6420434
[TBL] [Abstract][Full Text] [Related]
5. Alcohol effects on naloxone-stimulated luteinizing hormone, follicle-stimulating hormone and prolactin plasma levels in female rhesus monkeys.
Mello NK; Mendelson JH; Bree MP; Skupny A
J Pharmacol Exp Ther; 1988 Jun; 245(3):895-904. PubMed ID: 3133465
[TBL] [Abstract][Full Text] [Related]
6. Opioid regulation of pituitary gonadotropins and prolactin in women using oral contraceptives.
Snowden EU; Khan-Dawood FS; Dawood MY
Am J Obstet Gynecol; 1986 Feb; 154(2):440-4. PubMed ID: 3080893
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal evaluation of the luteal phase and its transition into the follicular phase.
Vermesh M; Kletzky OA
J Clin Endocrinol Metab; 1987 Oct; 65(4):653-8. PubMed ID: 3116029
[TBL] [Abstract][Full Text] [Related]
8. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
Quigley ME; Sheehan KL; Casper RF; Yen SS
J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
[TBL] [Abstract][Full Text] [Related]
9. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
[TBL] [Abstract][Full Text] [Related]
10. Reduced frequency of pulsatile luteinizing hormone secretion in the luteal phase of the rhesus monkey. Involvement of endogenous opiates.
Van Vugt DA; Lam NY; Ferin M
Endocrinology; 1984 Sep; 115(3):1095-101. PubMed ID: 6745188
[TBL] [Abstract][Full Text] [Related]
11. Corpus luteum insufficiency induced by a rapid gonadotropin-releasing hormone-induced gonadotropin secretion pattern in the follicular phase.
Soules MR; Clifton DK; Bremner WJ; Steiner RA
J Clin Endocrinol Metab; 1987 Sep; 65(3):457-64. PubMed ID: 3114301
[TBL] [Abstract][Full Text] [Related]
12. Naloxone stimulation of luteinizing hormone secretion in the female monkey: influence of endocrine and experimental conditions.
Van Vugt DA; Bakst G; Dyrenfurth I; Ferin M
Endocrinology; 1983 Nov; 113(5):1858-64. PubMed ID: 6414806
[TBL] [Abstract][Full Text] [Related]
13. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
[TBL] [Abstract][Full Text] [Related]
14. Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids.
Cetel NS; Quigley ME; Yen SS
J Clin Endocrinol Metab; 1985 Jan; 60(1):191-6. PubMed ID: 3964791
[TBL] [Abstract][Full Text] [Related]
15. [Study of the correlation between gonadotropin- and prolactin-releasing systems in women in the luteal phase and early pregnancy].
Kubota T; Nishi N; Saito M; Suzuki A; Yaoi Y; Kumasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Apr; 38(4):545-53. PubMed ID: 3084684
[TBL] [Abstract][Full Text] [Related]
16. Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma.
Quigley ME; Sheehan KL; Casper RF; Yen SS
J Clin Endocrinol Metab; 1980 Mar; 50(3):427-30. PubMed ID: 7358828
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
[TBL] [Abstract][Full Text] [Related]
18. Plasma gastrointestinal hormones during spontaneous and induced menstrual cycles.
Holst N; Jenssen TG; Burhol PG; Haug E; Forsdahl F
J Clin Endocrinol Metab; 1989 Jun; 68(6):1160-6. PubMed ID: 2498386
[TBL] [Abstract][Full Text] [Related]
19. Patterns of serum LH and FSH in response to 4-hour infusions of luteinizing hormone releasing hormone in normal women during menstrual cycle, on oral contraceptives, and in postmenopausal state.
de Kretser DM; Burger HG; Dumpys R
J Clin Endocrinol Metab; 1978 Feb; 46(2):227-35. PubMed ID: 374423
[TBL] [Abstract][Full Text] [Related]
20. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
